Literature DB >> 6940056

Danazol inhibition of steroidogenesis in the human corpus luteum.

R L Barbieri, R Osathanondh, K J Ryan.   

Abstract

In human corpus luteum (CL) microsomes, danazol inhibited 3 beta-hydroxysteroid dehydrogenase, 17,20-lyase, 17 alpha-hydroxylase, and 17 beta-hydroxysteroid dehydrogenase enzymes. Danazol did not inhibit aromatase. The observation that danazol can directly inhibit multiple enzymes of CL steroidogenesis may provide a molecular basis for explaining previous reports that danazol inhibits CL steroidogenesis in the monkey in vivo.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6940056

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  4 in total

1.  Corpus luteum dysfunction and the epidemiology of breast cancer: a reconsideration.

Authors:  B M Sherman; R B Wallace; S G Korenman
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

2.  [Megestrol acetate in various doses in the treatment of metastatic breast carcinoma--clinical and endocrinologic studies].

Authors:  H E Wander; H C Blossey; G A Nagel; D Emrich
Journal:  Klin Wochenschr       Date:  1985-04-01

3.  [High dose medroxyprogesteroneacetate in metastasizing breast cancer: correlations between course of the disease and hormone profiles].

Authors:  H E Wander; C Blossey; J Köbberling; G A Nagel
Journal:  Klin Wochenschr       Date:  1983-06-01

Review 4.  Benefits and risks of pharmacological agents used for the treatment of menorrhagia.

Authors:  Samendra Nath Roy; Siladitya Bhattacharya
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.